# A Trial of Tadalafil and Glycemic Traits

> **NCT01444651** · PHASE3 · COMPLETED · sponsor: **Thomas J. Wang, MD** · enrollment: 73 (actual)

## Conditions studied

- Cardiovascular Disease
- Insulin Resistance
- Glucose Intolerance
- Obesity

## Interventions

- **DRUG:** Tadalafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01444651
- **Lead sponsor:** Thomas J. Wang, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2017-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444651, "A Trial of Tadalafil and Glycemic Traits". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01444651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*